Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identification of a molecule that recognizes HIV in immune cells

05.06.2015

In collaboration with colleagues from California and New York, researchers of the Paul-Ehrlich-Institut have identified a cytosolic receptor which enables cells of the immune system to recognize HIV and to trigger an immune response. The findings of the researchers may be a useful tool for creating an effective endogenous immune response against HIV and helpful to boost vaccine responses. Cell reports on the results of this research work in its online edition of 04.06.2015.

Particular immune cells of the body called dendritic cells are in principle capable of recognizing HIV-1 as foreign invader. HIV-1, usually just referred to as HIV, causes the immune deficiency disease AIDS (acquired immunodeficiency syndrome).


Two HI-Viruses outside the cell (green).

Source: PEI

Up to now, it has been unclear how the cells identify the virus as "foreign". In collaboration with colleagues from the Sanford Burnham Medical Research Institute, La Jolla, California and the Icahn School of Medicine at Mount Sinai, New York, Dr Renate König, head of the research group "Cellular Aspects of Pathogen-Host Interactions" at the Paul-Ehrlich-Institut and her research team have discovered that polyglutamine binding protein 1 plays an important role in this mechanism.

They have demonstrated that this protein recognizes and binds to specific retroviral DNA. Although the genome of retroviruses, which also includes HIV, is normally present as RNA, it must first be transcribed into DNA, before it can integrate into the genome of the host cell. PQBP1 binds to the viral DNA and, moreover, binds to an additional protein called cyclic GMP-AMP synthase. It is not until this connection has been made that cGAS can activate a signal pathway which in turn activates the innate immune system and in turn, the specific immune system.

"With PQBP1, we have identified an important receptor which mediates the recognition of HIV by the cell and the immune system", as Dr König described the research results. Up to now, it was assumed that cGAS alone was able to recognize foreign DNA. The researchers were now able to identify an additional important module in this mechanism.

Without PQBP1, dendritic cells are unable to recognize HIV. This was shown by Dr König and colleagues by investigating blood samples taken from patients suffering from Renpenning syndrome. In patients with this neurodegenerative disorder, the gene for PQBP1 has mutated and the protein is therefore not functional. The retroviral DNA of these patients’ immune cells could not bind to the protein so in turn cGAS signaling is not activated.

In principle, dendritic cells harbor the mechanism described here, which permits the activation of an immune response after the contact with retroviral DNA. Thus, the identified mechanism may guide potential treatment approaches. As Dr König explained the possible benefit from the findings: "Activation of this mechanism by an adjuvant could improve the immune response against HIV in the body and could thus also be used in immune therapy".

Original publication

Yoh SM, Schneider M, Seifried J, Soonthomvacharin S, Akleh RE, Olivieri KC, De Jesus PD, Ruan de Castro CE, Ruiz PA, Germanaud D, des Portes V, García-Sastre A, König R, Chanda SK (2015): PQBP1 is a Proximal Sensor of HIV-1 DNA and Initiates cGAS-dependent Innate Immune Signaling.
Cell Jun 4 [Epub ahead of print].


The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.

Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.

The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).

Weitere Informationen:

http://www.cell.com/cell/abstract/S0092-8674%2815%2900525-5 Publication (Abstract)
http://www.pei.de/EN/information/journalists-press/press-releases/2015/07-identi... This Press Release on the PEI-Website

Dr. Susanne Stöcker | idw - Informationsdienst Wissenschaft

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

Bodyguards in the gut have a chemical weapon

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>